Financial instruments (Tables)

9 Months Ended

12 Months Ended

Dec. 31, 2023

Mar. 31, 2023

Fair Value Disclosures [Abstract]

Schedule of Financial Instruments Measured at Fair Value on Recurring Basis

The following table represents the fair value hierarchy for the Company’s financial instruments measured at fair value on a recurring basis as of December 31, 2023:

	December 31, 2023
	Fair Value Measured using
Particulars	Level 1		Level 2		Level 3		Total
Financial liabilities:
Convertible promissory notes		1,029,374		—		—		1,029,374
		1,029,374		—		—		1,029,374

	December 31, 2023
	Fair Value Measured using
Particulars	Level 1		Level 2		Level 3		Total
Financial assets:
Forward purchase agreement		—		—		24,462,103		24,462,103
		—		—		24,462,103		24,462,103

The following table represents the fair value hierarchy for the Company’s financial instruments measured at fair value on a recurring basis as of March 31, 2022:

	March 31, 2022
	Fair Value Measured using
Particulars	Level 1		Level 2		Level 3		Total
Financial liabilities:
Share warrants		—		—		68,675		68,675
Convertible notes		—		—		23,032,002		23,032,002
				—		23,100,677		23,100,677

Schedule of Reconciliation of the Company's Financial Liabilities Measured and Recorded at Fair Value on a Recurring Basis

The following table presents a reconciliation of the Company’s financial liabilities measured and recorded at fair value on a recurring basis as of March 31, 2023 and 2022, using significant unobservable inputs (Level 3):

	Warrants		Convertible notes
Balance as of March 31, 2022		68,675		23,032,002
Change in fair value		34,484		974,890
Conversion of convertible notes into preferred stock		—		24,006,892
Exercise of share warrants		103,159		—
Balance as of March 31, 2023		—		—